MarketsStocksPANACEABIO
PA

Panacea Biotec Ltd

NSE: PANACEABIOBSE: 531349Healthcare
Download Research Report7-page PDF
553.00
+2.37%
NSE · auto-updates while market open
Prev Close
₹447.50
Day High
₹562.65
Day Low
₹525.00
Mkt Cap
₹3,448 Cr
P / E
-
P / B
4.1
ROE
-0.9%
52W High
₹577.65
52W Low
₹292.40
Key Metrics
Market Cap
₹3,448 Cr
P / E
-
P / B
4.14
EV / EBITDA
68.28
ROCE
-0.1%
ROE
-0.9%
Debt / Equity
0.03
Book Value
₹136.19
EPS
-
Div Yield
0.0%
Face Value
₹1
Promoter Holding
72.5%
Revenue · ₹ Cr
544
FY20
625
FY21
661
FY22
460
FY23
559
FY24
559
FY25
640
FY26
Net Profit · ₹ Cr
1.1k
-194
-148
-34
-1
-9
-7
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹0.1
₹4.3
₹176.0
₹-31.7
₹-24.1
₹-5.5
₹-0.2
FY16FY19FY20FY21FY22FY23FY24
P / E Ratio · price ÷ TTM EPS
091181272231890-54Jun 21Feb 23Oct 24Jun 26
P/E 218.3×Median 0.8×TTM EPS
Q1 2026 snapshot
Sales
₹169 Cr
Operating profit
-
OPM
-
Net profit
₹-1 Cr
EPS
₹0.08
Scorecard · 7 axes
Quality
Weak
43/100
Valuation
-
Growth
Weak
+3.5%
Profitability
Bad
-0.5%
Performance
Avg
+14.6%
Entry Point
Bad
96%
Red Flags
Strong
0 flags
Shareholding Pattern
72.5%Promoter
Promoter72.5%
FII1.6%
DII2.0%
Public23.9%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue163.49141.12172.37147.53167.47169.3
Net Profit4.44-1.993.96-14.013.89-1
NPM %2.7%-1.4%2.3%-9.5%2.3%-0.6%
AlertPre-trade